Chemokine (C-C Motif) Ligand 15 (CCL15) (AA 22-113) Peptide
CCL15
适用: 人
宿主: 大肠杆菌（E. Coli）
SDS
1 image
-
- 抗原 See all CCL15 products
- CCL15 (Chemokine (C-C Motif) Ligand 15 (CCL15))
- 蛋白类型
- Recombinant
- 蛋白结构域
- AA 22-113
- 宿主
- 人
- 资源
- 大肠杆菌（E. Coli）
- 应用范围
- SDS-PAGE (SDS)
- 序列
- MQFINDAETE LMMSKLPLEN PVVLNSFHFA ADCCTSYISQ SIPCSLMKSY FETSSECSKP GVIFLTKKGR QVCAKPSGPG VQDCMKKLKP YSI
- 产品特性
-
Purified recombinant Human CCL15 protein
Expression System: E.coli - 纯度
- > 95 % pure
-
-
- 应用备注
- CCL15 protein has been used in SDS PAGE and may be suitable for use in other assays to be determined by the end user.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5 mg/mL
- 缓冲液
- Supplied as a liquid in PBS, pH 7.4, containing 10 % glycerol.
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- RT/-20 °C
- 储存方法
- Store at 4 °C for short term storage (1/2 weeks). Aliquot and store at -20 °C or - 70 °C for long term storage.
-
- 抗原
- CCL15 (Chemokine (C-C Motif) Ligand 15 (CCL15))
- 别名
- HCC-2 Peptide, HMRP-2B Peptide, LKN-1 Peptide, LKN1 Peptide, MIP-1 delta Peptide, MIP-1D Peptide, MIP-5 Peptide, MRP-2B Peptide, NCC-3 Peptide, NCC3 Peptide, SCYA15 Peptide, SCYL3 Peptide, SY15 Peptide, C-C motif chemokine ligand 15 Peptide, CCL15 Peptide
- 背景
-
Chemokine (C-C motif) ligand 15, also known as CCL15, is a small cytokine belonging to the CC chemokine family that is also known as thymus and activation regulated chemokine. CCL15 induces changes in intracellular calcium concentration in monocytes and is thought to act through the CCR1 receptor. This gene expresses both monocistronic and bicistronic transcripts, which encode the same protein. Recombinant human CCL15 protein was expressed in E. coli and purified by using conventional chromatography techniques.
Alternative Names: NCC3 protein, MIP-5NCC-3 protein, CCL 15 protein, LKN1 protein, CCL15, CCL-15, MIP-1d protein, HMRP-2B protein, HCC-2 protein, CCL-15 protein, Lkn-1 protein, SCYL3 protein, SY15 protein, CCL 15, SCYA15 protein, Chemokine (C-C motif) ligand 15 protein - 分子量
- 10.3 kDa (93 AA)
-
You are here:
